Giulia Russo

5PUBLICATIONS
7CO-AUTHORS
Molecular medicineGene and molecular therapyNanotoxicology, health and safetyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Safety Profile of Zavegepant in the Treatment of Acute Migraine: Insights from the FDA Adverse Event Monitoring System Database.

|Jun 13, 2025
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023).

Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala

|Mar 17, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System.

Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala

|Oct 26, 2024
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System.

Giuseppe Cicala, Giulia Russo, Vincenza Santoro

|Mar 28, 2024
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data.

Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo

Pageof 1

Frequent Collaborators

5 joint publications

Maria Antonietta Barbieri

5 joint publications

Edoardo Spina

4 joint publications

Giuseppe Cicala

2 joint publications

Nicola Silvestris